Difference Between Myotonic Dystrophy Type 1 and Type 2?
At a Glance
Myotonic dystrophy type 1 (DM1) and type 2 (DM2) are completely distinct genetic conditions. DM1 typically causes weakness in the hands and feet and is more severe. DM2 causes weakness in the hips and shoulders, progresses slower, and is often accompanied by significant muscle pain.
If you have been diagnosed with myotonic dystrophy type 2 (DM2), you might be wondering if it will eventually progress into myotonic dystrophy type 1 (DM1). The short answer is no: DM2 will never “turn into” or progress to DM1 [1][2].
A common misconception is that the “types” (1 and 2) refer to stages of disease severity, like stages of cancer. In reality, DM1 and DM2 are two completely distinct genetic conditions [3][1]. Because their root causes are located on completely different genes, having one does not mean you will eventually develop the other [1][2].
Different Genetic Causes
Both conditions are caused by genetic mutations known as repeat expansions, which happen when a small section of DNA is abnormally repeated over and over. However, the exact genes and DNA codes involved are completely different:
| Feature | Myotonic Dystrophy Type 1 (DM1) | Myotonic Dystrophy Type 2 (DM2) |
|---|---|---|
| Gene Affected | DMPK | CNBP |
| Mutation Code | CTG repeat | CCTG repeat |
| Primary Weakness | Distal (hands, feet) | Proximal (hips, shoulders) |
Because the root causes are located on completely different genes, they remain permanently separate clinical diagnoses [1][2]. The only way to definitively tell them apart is through a genetic test [1][4].
Severity and Pace of Progression
Patients often wonder which type is “worse.” Generally, DM2 has a milder clinical course and progresses much more slowly than DM1 [5][1].
While DM1 can sometimes present at birth or childhood and progress rapidly, DM2 almost exclusively begins in adulthood [6][3]. The progression of DM2 typically happens very gradually over years or even decades [5][1]. While it can cause significant disability over time, the long-term outlook for maintaining independence is generally more favorable for DM2 than for DM1 [5].
Different Patterns of Muscle Weakness
While both conditions share symptoms like myotonia (difficulty relaxing muscles after contracting them), they typically affect different parts of the body:
- Distal weakness in DM1: People with DM1 usually experience weakness first in their distal muscles, which are the muscles furthest from the center of the body [2][7]. This includes the hands, lower legs, feet, and sometimes the muscles of the face and neck [2][1].
- Proximal weakness in DM2: In contrast, DM2 is classically known for causing weakness in the proximal muscles, which are the muscles closest to the body’s core [2][1]. People with DM2 are more likely to notice weakness in their hips, thighs, and shoulders [2][7].
How Management Differs
Because the conditions affect the body differently, your daily management will look different from someone with DM1. For example:
- Physical Therapy: A patient with DM1 might need leg braces for “foot drop” or occupational therapy for hand grip issues. As a DM2 patient, your physical therapy will likely focus more on maintaining hip and shoulder strength to help you get out of chairs or lift objects [7][2].
- Pain Management: Severe muscle pain is a very frequent and distinct symptom in DM2 that significantly affects quality of life, meaning pain management strategies will likely be a much bigger focus of your care [8].
Multisystem Symptoms
Both DM1 and DM2 are “multisystemic,” meaning they can affect more than just the muscles, including the gastrointestinal tract and endocrine system [9][2].
Importantly, cardiac involvement (like heart rhythm issues or arrhythmias) is a serious concern for both types [10][1]. Because these heart issues can be silent at first, you should ask your doctor about scheduling a baseline electrocardiogram (EKG) and establishing a routine heart screening schedule [10][1]. Your healthcare team will tailor your specific monitoring based on your unique symptoms [2][11].
Common questions in this guide
Will myotonic dystrophy type 2 eventually turn into type 1?
Which is worse, myotonic dystrophy type 1 or type 2?
How do the muscle weakness symptoms differ between DM1 and DM2?
Why do I need a heart check if I have myotonic dystrophy?
Is severe muscle pain common in myotonic dystrophy?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How frequently should I be screened for heart rhythm issues, and should I be referred to a cardiologist for a baseline EKG?
- 2.Could you refer me to a physical therapist who can help me build a routine specifically targeting my proximal muscle strength (hips and shoulders)?
- 3.What options are available for managing the muscle pain that often comes with DM2?
- 4.Are there specific endocrine or eye screenings (like checking for cataracts) I should schedule this year?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (11)
- 1
Myotonic dystrophy type 2: the 2020 update.
Meola G
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2020; (39(4)):222-234 doi:10.36185/2532-1900-026.
PMID: 33458578 - 2
Myotonic Dystrophy.
Perez PG
Continuum (Minneapolis, Minn.) 2025; (31(5)):1437-1461 doi:10.1212/cont.0000000000001621.
PMID: 41037177 - 3
Endurance exercise leads to beneficial molecular and physiological effects in a mouse model of myotonic dystrophy type 1.
Sharp L, Cox DC, Cooper TA
Muscle & nerve 2019; (60(6)):779-789 doi:10.1002/mus.26709.
PMID: 31509256 - 4
Development and Validation of a New Molecular Diagnostic Assay for Detection of Myotonic Dystrophy Type 2.
Valaperta R, Lombardi F, Cardani R, et al.
Genetic testing and molecular biomarkers 2015; (19(12)):703-9 doi:10.1089/gtmb.2015.0135.
PMID: 26505324 - 5
Myotonic Dystrophy-2: Unusual Phenotype Due to a Small CCTG-expansion.
J F, C S, A RF, et al.
Balkan journal of medical genetics : BJMG 2018; (21(2)):39-43 doi:10.2478/bjmg-2018-0024.
PMID: 30984523 - 6
Clinical and genetic characteristics of childhood-onset myotonic dystrophy.
Stokes M, Varughese N, Iannaccone S, Castro D
Muscle & nerve 2019; (60(6)):732-738 doi:10.1002/mus.26716.
PMID: 31520483 - 7
Sporadic Myotonic Dystrophy Type 2 in a Japanese Patient.
Miyashita K, Ii Y, Matsuyama H, et al.
Internal medicine (Tokyo, Japan) 2023; (62(20)):3027-3031 doi:10.2169/internalmedicine.0425-22.
PMID: 36792202 - 8
Qualitative and Quantitative Aspects of Pain in Patients With Myotonic Dystrophy Type 2.
van Vliet J, Tieleman AA, Verrips A, et al.
The journal of pain 2018; (19(8)):920-930 doi:10.1016/j.jpain.2018.03.006.
PMID: 29601898 - 9
High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2.
Hilbert JE, Barohn RJ, Clemens PR, et al.
Neurology 2017; (89(13)):1348-1354 doi:10.1212/WNL.0000000000004420.
PMID: 28855409 - 10
Cardiac Pathology in Myotonic Dystrophy Type 1.
Mahadevan MS, Yadava RS, Mandal M
International journal of molecular sciences 2021; (22(21)) doi:10.3390/ijms222111874.
PMID: 34769305 - 11
Comprehensive Cardiovascular Management of Myotonic Dystrophy Type 1 Patients: A Report from the Italian Neuro-Cardiology Network.
Russo V, Antonini G, Massa R, et al.
Journal of cardiovascular development and disease 2024; (11(2)) doi:10.3390/jcdd11020063.
PMID: 38392277
This page explains the differences between myotonic dystrophy type 1 and type 2 for educational purposes. Always consult your neurologist or healthcare team for specific guidance on your diagnosis and care plan.
Get notified when new evidence is published on Myotonic dystrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.